» Articles » PMID: 18204855

Pancreatic Stellate Cells--role in Pancreas Cancer

Overview
Specialty General Surgery
Date 2008 Jan 22
PMID 18204855
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Adenocarcinomas of the pancreas are characterized by a rapid progression, an early metastasis, a limited response to chemo- and radiotherapy, and an intense fibrotic reaction known as tumor desmoplasia. Carcinoma cells are surrounded by a dense stroma consisting of myofibroblast-like cells, collagens, and fibronectin.

Materials And Methods: This review describes the interaction of activated pancreatic stellate cells (myofibroblast-like cells) with tumor cells in pancreas adenocarcinomas. Our data were obtained in cell culture experiments and in in vivo investigations.

Results: Carcinoma cells produce soluble mediators and stimulate motility, proliferation, matrix-, and MMP synthesis of stellate cells. Vice versa-activated stellate cells release mitogens, stimulating proliferation of cancer cells. Cancer cell proliferation and resistance to apoptosis might further be induced by the microenvironment (extracellular matrix), which is primarily provided by stellate cells. A very important aspect in the interaction of stellate cells with cancer cells is the expression of EMMPRIN (extracellular matrix metalloproteinase inducer) by cancer cells, the shedding of the extracellular part of EMMPRIN by matrix metalloproteinases (MMPs), and the induction of MMPs in stellate cells by soluble EMMPRIN. In particular, the stellate cells in close proximity to tumor cells therefore express MMPs and degrade connective tissue.

Conclusion: Through complex interactions between stellate cells and carcinoma cells, tumor progression and cancer cell invasion are accelerated. As we gain better understanding of these mechanisms, adequate therapies to reduce tumor cell invasion and cancer progression might be developed.

Citing Articles

Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment.

Purushothaman A, Oliva-Ramirez J, Treekitkarnmongkol W, Sankaran D, Hurd M, Putluri N Int J Mol Sci. 2023; 24(19).

PMID: 37834100 PMC: 10572854. DOI: 10.3390/ijms241914652.


Tumor Stroma Area and Other Prognostic Factors in Pancreatic Ductal Adenocarcinoma Patients Submitted to Surgery.

Amaral M, Amaral M, Freitas J, Oliveira R, Serodio M, Cipriano M Diagnostics (Basel). 2023; 13(4).

PMID: 36832145 PMC: 9955223. DOI: 10.3390/diagnostics13040655.


Alpha Smooth Muscle Actin (αSMA) Immunohistochemistry Use in the Differentiation of Pancreatic Cancer from Chronic Pancreatitis.

Winter K, Dzieniecka M, Strzelczyk J, Wagrowska-Danilewicz M, Danilewicz M, Malecka-Wojciesko E J Clin Med. 2021; 10(24).

PMID: 34945100 PMC: 8707555. DOI: 10.3390/jcm10245804.


A topology-preserving dimensionality reduction method for single-cell RNA-seq data using graph autoencoder.

Luo Z, Xu C, Zhang Z, Jin W Sci Rep. 2021; 11(1):20028.

PMID: 34625592 PMC: 8501122. DOI: 10.1038/s41598-021-99003-7.


Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions.

Suri R, Zimmerman J, Burkhart R Ann Pancreat Cancer. 2021; 3.

PMID: 33889840 PMC: 8059695. DOI: 10.21037/apc-20-29.


References
1.
Buchholz M, Kestler H, Holzmann K, Ellenrieder V, Schneiderhan W, Siech M . Transcriptome analysis of human hepatic and pancreatic stellate cells: organ-specific variations of a common transcriptional phenotype. J Mol Med (Berl). 2005; 83(10):795-805. DOI: 10.1007/s00109-005-0680-2. View

2.
Liotta L, Kohn E . The microenvironment of the tumour-host interface. Nature. 2001; 411(6835):375-9. DOI: 10.1038/35077241. View

3.
Sidhu S, Mengistab A, Tauscher A, LaVail J, Basbaum C . The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene. 2004; 23(4):956-63. DOI: 10.1038/sj.onc.1207070. View

4.
Bachem M, Schneider E, Gross H, Weidenbach H, Schmid R, Menke A . Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology. 1998; 115(2):421-32. DOI: 10.1016/s0016-5085(98)70209-4. View

5.
Taylor P, Woodfield R, Hodgkin M, Pettitt T, Martin A, Kerr D . Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A(2) and 5-lipoxygenase catalyzed pathway. Oncogene. 2002; 21(37):5765-72. DOI: 10.1038/sj.onc.1205702. View